PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Phenotype | C0023895|liver disease |
| Sentences | 8 |
| PubMedID- 25148949 | [pulmonary hypertension in liver diseases]. |
| PubMedID- 20714839 | Background/purpose: the diagnosis of porto-pulmonary hypertension (pphn) in patients with end-stage liver disease at the time of surgery is not an uncommon occurrence. |
| PubMedID- 22447257 | pulmonary hypertension in patients with liver disease or portal hypertension can be due to multiple mechanisms, including hyperdynamic (high-flow) state, increased pulmonary venous congestion, and vascular constriction or obstruction of the pulmonary arterial bed. |
| PubMedID- 21760840 | pulmonary hypertension that develops in patients with liver disease and portal hypertension is called portopulmonary hypertension (ppht) [table 1]. |
| PubMedID- 21280186 | End-stage liver disease with severe portopulmonary hypertension (pphtn), which is refractory to vasodilator therapies, is a contraindication for isolated liver transplantation (lt) because of the high mortality rate. |
| PubMedID- 20002632 | The incidence of porto-pulmonary hypertension (pphn) in patients with end stage liver disease is 8.5%. |
| PubMedID- 25885880 | Portopulmonary hypertension in liver disease presenting in childhood. |
| PubMedID- 21389799 | Every clinician who manages patients with chronic liver disease complaining of dyspnea should consider portopulmonary hypertension because this disorder requires special treatment. |
Page: 1